Back to Search Start Over

Evaluation of the Possible Anticonvulsant Effect of Δ 9 -Tetrahydrocannabinolic Acid in Murine Seizure Models.

Authors :
Benson MJ
Anderson LL
Low IK
Luo JL
Kevin RC
Zhou C
McGregor IS
Arnold JC
Source :
Cannabis and cannabinoid research [Cannabis Cannabinoid Res] 2022 Feb; Vol. 7 (1), pp. 46-57. Date of Electronic Publication: 2020 Sep 09.
Publication Year :
2022

Abstract

Introduction: The cannabinoid Δ <superscript>9</superscript> -tetrahydrocannabinolic acid (Δ <superscript>9</superscript> -THCA) has long been suggested in review articles and anecdotal reports to be anticonvulsant; yet, there is scant evidence supporting this notion. The objective of this study was to interrogate the anticonvulsant potential of Δ <superscript>9</superscript> -THCA in various seizure models-the Scn1a <superscript>+/-</superscript> mouse model of Dravet syndrome, the 6-Hz model of psychomotor seizures and the maximal electroshock (MES) model of generalized tonic-clonic seizures. Materials and Methods: We examined the effect of acute Δ <superscript>9</superscript> -THCA treatment against hyperthermia-induced seizures, and subchronic treatment on spontaneous seizures and survival in the Scn1a <superscript>+/-</superscript> mice. We also studied the effect of acute Δ <superscript>9</superscript> -THCA treatment on the critical current thresholds in the 6-Hz and MES tests using outbred Swiss mice. Highly purified Δ <superscript>9</superscript> -THCA was used in the studies or a mixture of Δ <superscript>9</superscript> -THCA and Δ <superscript>9</superscript> -THC. Results: We observed mixed anticonvulsant and proconvulsant effects of Δ <superscript>9</superscript> -THCA across the seizure models. Highly pure Δ <superscript>9</superscript> -THCA did not affect hyperthermia-induced seizures in Scn1a <superscript>+/-</superscript> mice. A Δ <superscript>9</superscript> -THCA/Δ <superscript>9</superscript> -THC mixture was anticonvulsant in the 6-Hz threshold test, but purified Δ <superscript>9</superscript> -THCA and Δ <superscript>9</superscript> -THC had no effect. Conversely, both Δ <superscript>9</superscript> -THCA and Δ <superscript>9</superscript> -THC administered individually were proconvulsant in the MES threshold test but had no effect when administered as a Δ <superscript>9</superscript> -THCA/Δ <superscript>9</superscript> -THC mixture. The Δ <superscript>9</superscript> -THCA/Δ <superscript>9</superscript> -THC mixture, however, increased spontaneous seizure severity and increased mortality of Scn1a <superscript>+/-</superscript> mice. Discussion: The anticonvulsant profile of Δ <superscript>9</superscript> -THCA was variable depending on the seizure model used and presence of Δ <superscript>9</superscript> -THC. Because of the unstable nature of Δ <superscript>9</superscript> -THCA, further exploration of Δ <superscript>9</superscript> -THCA through formal anticonvulsant drug development is problematic without stabilization. Future studies may better focus on determining the mechanisms by which combined Δ <superscript>9</superscript> -THCA and Δ <superscript>9</superscript> -THC alters seizure thresholds, as this may uncover novel targets for the control of refractory partial seizures.

Details

Language :
English
ISSN :
2378-8763
Volume :
7
Issue :
1
Database :
MEDLINE
Journal :
Cannabis and cannabinoid research
Publication Type :
Academic Journal
Accession number :
33998858
Full Text :
https://doi.org/10.1089/can.2020.0073